最新观点
Insights From Our Experts
Articles
Challenges (and Solutions) to Rapid Omnichannel Transformation
Omnichannel can offer countless benefits and notably improve provider and patient journeys. But current marketplace challenges are disrupting success with omnichannel efforts for some manufacturers, and hindering their quality of service to healthcare professionals and the…
Ask the Attorneys: What Keeps Them Up at Night
EVERSANA’s Mike Kurland, Vice President, Revenue Management and Compliance, joined a panel of industry experts to present, “Ask the Attorneys: What Keeps Them Up at Night?” at Informa Connect’s Medical Drug Rebate Program Summit. Session Summary…
Brand Planning – Fitting Financial and Copay Services into Existing Models
EVERSANA’s Kevin O’Meara, Vice President, Patient Services Solutions, and Chris Lagoerio, Director, Revenue Management, presented a session, “Brand Planning – Fitting Financial and Copay Services into Existing Models,” at Informa Connect’s Copay, Reimbursement and Access Congress.…
Digital-First Future and the “Data Flywheel”: How Can Pharma Use the Combination of Data, AI, and Content to Drive Successful Product Launches
In this episode of Pharma Launch Secrets, Bozidar Jovicevic, CEO of Evermed, is joined by Scott Snyder, Chief Digital Officer at EVERSANA to discuss: What is the best way to orchestrate personalized digital experiences for HCPs…
Developing Best-in-class Copay Programs for Gross-to-Net
Importance of Copay Assistance Programs A copay assistance program is an invaluable strategic cost-saving tool that biopharmaceutical companies integrate into their patient services offering. These programs are used to support a brand’s value proposition, while offsetting…
Elevate Your Brand to New Heights by Utilizing National Account Managers’ Singular Skills, Resources and Experience in an Ever-changing Marketplace
Launching new therapies is a vast undertaking for any pharmaceutical company. Setting up a product for success requires a great deal of expense, research, strategic planning and effective collaboration, just to name a few essential elements. EVERSANA’s National…
The New Role of Medical Field Teams and Their Impact on Launch Success
A combination of industry challenges and an influx of complex therapies in the market, have impacted Medical Science Liaisons (MSLs), Clinical Trial Liaisons (CTLs) and Clinical Nurse Educators (CNEs). Susan Giacalone, MSN, BCMAS, MSL-BC, Vice President,…
How Specialty Pharmacies Can Elevate Your Channel and Distribution Strategy for HCP-administered Buy & Bill Products
A successful channel and distribution strategy for Buy & Bill (B&B) products should be centered around the partners you sell to and through. That means considering any third-party logistics (3PL) providers, specialty distributors (SD) and specialty…
AMA Scheduled to Deliberate Potential Approval of Additional Digital Medicine CPT Codes
As part of its upcoming meeting in mid-September, members of the American Medical Association’s (AMA) CPT Editorial Panel will consider several new Current Procedural Terminology (CPT) codes that identify digital diagnostic and therapeutic procedures. Between this…
Reimbursement Landscape for Digital Medicine Continues to Advance with CMS
The Centers for Medicare and Medicaid Services (CMS) recently announced several new payment and coding proposals that, once finalized, would recognize and advance the use of digital diagnostic and therapeutic modalities. In this week’s update, we…